Research study Program year 2020 Source: CMS Open Payments

Jak1 Dupilumab Comparator Study

Research payments

$3,838,536

808 payments

Through program year 2020, $3,838,536 in research payments was reported against Jak1 Dupilumab Comparator Study, across 808 payments, paid by Pfizer Inc..

Paid by: Pfizer Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$886,768	188
2019	Research	$2,951,768	620

Breakdown

Who paid Research payments · program years 2019–2020

Pfizer Inc. $3,838,536 808 payments

Who received the money Research payments · program years 2019–2020

Moonshine Research Center Inc Organisation paid for research $701,966 25 payments
C R Research Services USA Inc Organisation paid for research $259,483 14 payments
Crisor LLC Organisation paid for research $218,322 22 payments
Wellness Clinical Research LLC Organisation paid for research $204,349 24 payments
Center For Clinical Studies Ltd LLP Organisation paid for research $160,852 31 payments
Arlington Research Center Organisation paid for research $130,587 22 payments
Midwest Allergy Sinus Asthma Sc Organisation paid for research $127,790 18 payments
PMG Research of Raleigh LLC dba PMG Research of Cary Organisation paid for research $98,920 21 payments
Allergy Asthma Associates of Southern California dba Southern California Research Organisation paid for research $90,862 18 payments
Forward Clinical Trials INC Dba Forcare Clinical Research Organisation paid for research $84,824 15 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.